Portage (PRTG) Net earnings per share growth forecast for next year

Corporate company logo of Portage Biotech Inc. (PRTG)

Adherence to ethical standards and ESG principles ensures the sustainability of Portage Biotech Inc. (PRTG). A shift in the consensus growth estimate for net income confirms this status, where 0.00 serves as the current parameter value. The development of universal iNKT platforms to combat metastases complements the growth trajectory, yet a critical capital shortage and the threat of liquidation remain key risk factors.

Portage (PRTG): Net earnings per share growth forecast for next year from 07/04/2022 to 09/04/2025

Summary analytical data breakdowns for portagebiotech.com (PRTG)

- share price and consensus valuation forecast:
Stock Price Portage|PRTG - Consensus Target
- market capitalization details:
Market Value Portage Biotech|PRTG - Total Enterprise Value
- company book value details:
Net Assets per Single Share Portage Biotech|PRTG - Company Book Value|Market Value to Book Value Ratio portagebiotech.com|PRTG - Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Portage Biotech Inc.|PRTG - Long-Term Indebtedness to Equity|Short-Term Debt to Equity Ratio Portage Biotech|PRTG - Company Cumulative Debt|Debt to Book Value Portage Biotech|PRTG - Company Long-Term Loans and Borrowings|Company Current Liabilities Portage Biotech|Quick Ratio portagebiotech.com
- net income and valuation ratios data:
PRTG - Final Profit|Projected Future Earnings Portage Biotech Inc.|PRTG - Market Cap to Earnings|Future Price to Earnings Portage Biotech Inc.|PRTG - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Portage Biotech|PRTG - Operating profit EBITDA|Earnings per share for the last twelve months Portage Biotech|PRTG - Earnings per one share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months portagebiotech.com|PRTG - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Portage Biotech Inc.
- company sales and revenue statistics:
PRTG - Company Annual Revenue|Company Projected Revenue Portage|PRTG - Price to Sales|Price-to-Projected Revenue Ratio Portage Biotech
Fundamental company analysis:Portage
Finished products of Portage Biotech Inc

This indicator reflects the consensus forecast for earnings per share growth rates, measuring the gap between current market expectations and historical values. By analyzing the expected EPS dynamics for the next period, an investor can assess the probability of Portage Biotech Inc. (PRTG) capitalization through the success of immuno-oncology drug clinical trials or a potential acquisition by a strategic pharma behemoth.

Competitor analysis for Portage Biotech Inc.

INCY (Incyte Corp.) - Earnings growth forecast for next year|Expected earnings per share growth for next year HUTCHMED Corp (HCM)|Net earnings per share growth forecast for next year Nuvation Bio Inc. (NUVB)|DAWN - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Monopar Therapeutics Inc. MNPR|Inhibrx - Net earnings per share growth forecast for next year|IMAB - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Fennec|HRTX: Earnings growth forecast for next year|Net earnings per one share growth forecast for next year nuvectis.com NVCT|Expected earnings per share growth for next year CHRS|Expected net earnings per share growth next year Corbus Pharmaceuticals Holdings, Inc. CRBP|Expected earnings per share growth for next year CRDF (Cardiff Oncology, Inc.)|BYSI (BeyondSpring Inc) - Expected earnings per share trend next year|BioAtla - Expected earnings per share growth for next year|Projected earnings per share increase next year LIXT (lixte.com)|Citius Pharma - Earnings growth forecast for next year|Expected earnings per share trend next year CLRB (Cellectar Biosciences Inc)|BLRX: Earnings growth forecast for next year|Expected net earnings per share growth next year Can-Fite (CANF)|Net earnings per share growth forecast for next year Aprea Therapeutics Inc.|KZIA: Expected earnings per share trend next year|Earnings growth forecast for next year SLXN|Earnings growth forecast for next year nucana.com (NCNA)|Net earnings per share growth forecast for next year Chimerix, Inc CMRX|CYCC (Cyclacel, Inc.) - Net earnings per share change forecast for next year|GTHX: Expected earnings per share growth for next year|Expected net earnings per share growth next year kronosbio.com|Kintara Therapeutics, Inc. (KTRA) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year ONCT (Oncternal Therapeutics Inc)